Compare Cigna Corp (CI) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs SpaceX — how do they compare? Cigna Corp trades at $302.09 (market cap $80.55B), while SpaceX trades at $137.75 (market cap $1.83T). The key difference: SpaceX is far larger — about 22.7× Cigna Corp's market cap, and Cigna Corp pays a 2.05% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| CI | SPCX | |
|---|---|---|
Market Cap | $80.55B | $1.83T |
Sector | Health | Technology |
52-Week High | $311.00 | $202.09 |
52-Week Low | $244.41 | $135.00 |
Enterprise Value | $103.65B | $1.85T |
Dividend Yield | 2.05% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
SPCX trades at $139.14, down 4.33% over 24 hours, reflecting post-IPO volatility. The stock shows bearish technical signals with key support at $137 and resistance at $141. Fundamentally, the company reported 2025 revenue of $18.67B but a net loss of $4.94B, with negative profitability margins. Recent news highlights Nasdaq-100 inclusion and new Starlink partnerships, providing mixed sentiment amid high valuation concerns.
Outlook remains speculative with analyst consensus bullish (100% buy rating) and a $239.23 price target, but risks include sustained losses, high P/S ratio of 94.3, and competitive pressures. Investment appeal hinges on future profitability and execution of growth initiatives in the space sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
